Literature DB >> 36227435

Epidemiology and clinicopathological characteristics of native kidney disease in children in Flanders, Belgium.

Dries Deleersnijder1,2, Noël Knops3,4, Dominique Trouet5,6, Koen Van Hoeck6, Sevasti Karamaria7,8, Johan Vande Walle7,8, Reiner Mauel9, Louise Cools10, Gert Meeus11, Amélie Dendooven5,12, Johan De Meester13, Wim Laurens7,13, Ben Sprangers14,15.   

Abstract

BACKGROUND: The Flemish Collaborative Glomerulonephritis Group (FCGG) registry is a population-based kidney biopsy registry that has been including all native kidney biopsies performed in children in Flanders (Belgium), since 2017.
METHODS: From 2017 to 2020, 148 pediatric (< 18 years) native kidney biopsies were included. Each biopsy received a histopathological and final nephrological diagnosis, and concordance between both was assessed. Disease chronicity, summarized by the Mayo Clinic Chronicity Score, was determined on 122 biopsies with > 5 glomeruli.
RESULTS: Kidney biopsy rate was high (29.0 biopsies per million children per year), median age was 10.0 years (IQR 5.8-14.7), and boys predominated (56.1% males). A total of 140 biopsies (94.6%) showed a representative pathology result. Glomerular disease was most prevalent, with IgA nephropathy/IgA vasculitis (43 biopsies, 29.1%) and minimal change disease (MCD) (29 biopsies, 19.6%) being the overall most frequent diagnoses. In general, diagnostic concordance was high (80.7%). In Alport syndrome and focal segmental glomerulosclerosis (FSGS), concordance was lower, as the nephrological diagnosis was often determined by results of genetic analysis. Nephrotic syndrome was the most frequent indication for kidney biopsy (31.8%) and was mainly caused by MCD and FSGS. The degree of disease chronicity on kidney biopsies was generally low, although 27.3% of biopsies with a diagnosis of FSGS showed moderate-to-severe chronic damage.
CONCLUSIONS: The presented epidemiological findings validate data from previous European registry studies and may inspire kidney biopsy registries worldwide to implement novel features such as clinicopathological concordance and chronicity grading. A higher resolution version of the Graphical abstract is available as Supplementary information.
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

Entities:  

Keywords:  Epidemiology; Kidney biopsy; MCCS; Native kidney; Registry

Year:  2022        PMID: 36227435     DOI: 10.1007/s00467-022-05719-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  33 in total

1.  Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011.

Authors:  Dita Maixnerova; Eva Jancova; Jelena Skibova; Romana Rysava; Ivan Rychlik; Ondrej Viklicky; Miroslav Merta; Alexander Kolsky; Jana Reiterova; Michaela Neprasova; Jana Kidorova; Eva Honsova; Vladimir Tesar
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

2.  Spanish Registry of glomerulonephritis 2020 revisited: past, current data and new challenges.

Authors:  Juan M López-Gómez; Francisco Rivera
Journal:  Nefrologia (Engl Ed)       Date:  2020-07-06

3.  A proposal for standardized grading of chronic changes in native kidney biopsy specimens.

Authors:  Sanjeev Sethi; Vivette D D'Agati; Cynthia C Nast; Agnes B Fogo; An S De Vriese; Glen S Markowitz; Richard J Glassock; Fernando C Fervenza; Surya V Seshan; Andrew Rule; Lorraine C Racusen; Jai Radhakrishnan; Christopher G Winearls; Gerald B Appel; Ingeborg M Bajema; Anthony Chang; Robert B Colvin; H Terence Cook; Sundaram Hariharan; Loren P Herrera Hernandez; Neeraja Kambham; Michael Mengel; Karl A Nath; Helmut G Rennke; Pierre Ronco; Brad H Rovin; Mark Haas
Journal:  Kidney Int       Date:  2017-04       Impact factor: 10.612

4.  Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of Renal Biopsies in Children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology and Group of Renal Immunopathology of the Italian Society of Nephrology.

Authors:  R Coppo; B Gianoglio; M G Porcellini; S Maringhini
Journal:  Nephrol Dial Transplant       Date:  1998-02       Impact factor: 5.992

Review 5.  Approach to Kidney Biopsy: Core Curriculum 2022.

Authors:  Behzad Najafian; Mark A Lusco; Charles E Alpers; Agnes B Fogo
Journal:  Am J Kidney Dis       Date:  2022-02-04       Impact factor: 8.860

6.  The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.

Authors:  Anand Srivastava; Ragnar Palsson; Arnaud D Kaze; Margaret E Chen; Polly Palacios; Venkata Sabbisetti; Rebecca A Betensky; Theodore I Steinman; Ravi I Thadhani; Gearoid M McMahon; Isaac E Stillman; Helmut G Rennke; Sushrut S Waikar
Journal:  J Am Soc Nephrol       Date:  2018-06-04       Impact factor: 10.121

Review 7.  Renal Biopsy in 2015--From Epidemiology to Evidence-Based Indications.

Authors:  Marco Fiorentino; Davide Bolignano; Vladimir Tesar; Anna Pisano; Wim Van Biesen; Graziella D'Arrigo; Giovanni Tripepi; Loreto Gesualdo
Journal:  Am J Nephrol       Date:  2016-02-05       Impact factor: 3.754

8.  Frequency of renal pathology in Spain 1994-1999.

Authors:  Francisco Rivera; Juan Manuel López-Gómez; Rafael Pérez-García
Journal:  Nephrol Dial Transplant       Date:  2002-09       Impact factor: 5.992

9.  Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.

Authors:  Justyna Siwy; Petra Zürbig; Angel Argiles; Joachim Beige; Marion Haubitz; Joachim Jankowski; Bruce A Julian; Peter G Linde; David Marx; Harald Mischak; William Mullen; Jan Novak; Alberto Ortiz; Frederik Persson; Claudia Pontillo; Peter Rossing; Harald Rupprecht; Joost P Schanstra; Antonia Vlahou; Raymond Vanholder
Journal:  Nephrol Dial Transplant       Date:  2017-12-01       Impact factor: 5.992

10.  Biopsy or Biomarker? Children With Minimal Change Disease Have a Distinct Profile of Urinary Epidermal Growth Factor.

Authors:  Niels Lodeweyckx; Kristien Wouters; Kristien J Ledeganck; Dominique Trouet
Journal:  Front Pediatr       Date:  2021-11-25       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.